Seminars in Hematology
Volume 40, Issue 3 , Pages 221-232 , July 2003

Natural killer cell neoplasms: A distinctive group of highly aggressive lymphomas/leukemias

  • Michael M.C. Cheung

      Affiliations

    • *Address correspondence to Dr Michael M.C. Cheung, Department of Clinical Oncology, Room 1116, 11/F, Block R, Queen Elizabeth Hospital, Gascoigne Road, Kowloon, Hong Kong
    • Departments of Clinical Oncology and Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong
    • ,
  • John K.C. Chan

      Affiliations

    • Departments of Clinical Oncology and Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong
    • ,
  • Kit-Fai Wong

      Affiliations

    • Departments of Clinical Oncology and Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong

References 

  1. Abe Y, Muta K, Ohshima K, et al.  Subcutaneous panniculitis by Epstein-Barr virus-infected natural killer (NK) cell proliferation terminating in aggressive subcutaneous NK cell lymphoma. Am J Hematol. 2000;64:221–225
  2. Arber DA, Weiss LM, Albujar PF, et al.  Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol. 1993;17:392–399
  3. Chan JK. Natural killer cell neoplasms. Anat Pathol. 1998;3:77–145
  4. Chan JK, Ng CS, Lau WH, et al.  Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol. 1987;11:418–429
  5. Chan JK, Sin VC, Wong KF, et al.  Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997;89:4501–4513
  6. Chan JK, Tsang WY, Hui PK, et al.  T- and T/natural killer-cell lymphomas of the salivary gland: A clinicopathologic, immunohistochemical and molecular study of six cases. Hum Pathol. 1997;28:238–245
  7. Chan JK, Tsang WY, Lau WH, et al.  Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer. 1996;77:1198–1205
  8. Chan JK, Tsang WY, Pau MY. Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections. Hum Pathol. 1995;26:1139–1143
  9. Chan JKC, Jaffe ES, Ralfkiaer E. Blastic NK-cell lymphoma. In Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. In:  eds Jaffe ES,  Harris NL,  Stein H editor. Lyon, France: IARC Press,; 2001;p. 214–215
  10. Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. In:  eds Jaffe ES,  Harris NL,  Stein H, et al. editor. Lyon, France: IARC Press,; 2001;p. 204–207
  11. Chan JKC, Ng CS, Tsang WY. Nasal/nasopharyngeal lymphomas: An immunohistochemical analysis of 57 cases on frozen tissues. Mod Pathol. 1993;6:87A; (abstr)
  12. Chan JKC, Wong KF, Jaffe ES, et al.  Aggressive NK-cell leukemia. In Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. In:  eds Jaffe ES,  Harris NL,  Stein H, et al. editor. Lyon, France: IARC Press,; 2001;p. 198–200
  13. Cheung MM, Chan JK, Lau WH, et al.  Primary non-Hodgkin’s lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16:70–77
  14. Cheung MM, Chan JK, Lau WH, et al.  Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 2002;54:182–190
  15. Cheung MM, Chan JK, Wong KH. Early stage nasal NK/T cell lymphoma: Preliminary result of intensifying treatment with concurrent chemo-radiation and high dose chemotherapy. Ann Oncol. 2002;12:82; (abstr)
  16. Chinen K, Kaneko Y, Izumo T, et al.  Nasal natural killer cell/t-cell lymphoma showing cellular morphology mimicking normal lymphocytes. Arch Pathol Lab Med. 2002;126:602–605
  17. Chou WC, Chiang IP, Tang JL, et al.  Clonal disease of natural killer large granular lymphocytes in Taiwan. Br J Haematol. 1998;103:1124–1128
  18. Cuadra-Garcia I, Proulx GM, Wu CL, et al.  Sinonasal lymphoma: A clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol. 1999;23:1356–1369
  19. Dukers DF, Vermeer MH, Jaspars LH, et al.  Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype. J Clin Pathol. 2001;54:224–228
  20. Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, et al.  Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T- lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol. 1998;11:754–761
  21. Emile JF, Boulland ML, Haioun C, et al.  CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood. 1996;87:1466–1473
  22. Engellenner W, Golightly M. Large granular lymphocyte leukemia. Lab Med. 1991;22:454–456
  23. Fukuda J, Yoshihara T, Arai Y, et al.  Nasal NK-cell lymphoma. Rinsho Ketsueki. 1994;35:588–592
  24. Gaal K, Sun NC, Hernandez AM, et al.  Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol. 2000;24:1511–1517
  25. Gelb AB, van de Rijn M, Regula DP, et al.  Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol. 1994;25:953–960
  26. Goodlad JR, Fletcher CDM, Chan JKC, et al.  Primary soft tissue lymphoma: An analysis of 37 cases. J Pathol. 1996;179(suppl, abstr):42A
  27. Haedicke W, Ho FC, Chott A, et al.  Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood. 2000;95:3628–3630
  28. Harris NL, Jaffe ES, Diebold J, et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999;10:1419–1432
  29. Harris NL, Jaffe ES, Stein H, et al.  A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–1392
  30. Hart DN, Baker BW, Inglis MJ, et al.  Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood. 1992;79:2116–2123
  31. Herling M, Teitell MA, Shen RR, et al: TCL1 Expression in plasmacytoid dendritic cells (DC2) and the related CD4+ CD56+ blastic tumors of skin. Blood (in press)
  32. Ho FC, Srivastava G, Loke SL, et al.  Presence of Epstein-Barr virus DNA in nasal lymphomas of B and ‘T’ cell type. Hematol Oncol. 1990;8:271–281
  33. Imamura N, Kusunoki Y, Kawa-Ha K, et al.  Aggressive natural killer cell leukaemia/lymphoma: Report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol. 1990;75:49–59
  34. Ishihara S, Ohshima K, Tokura Y, et al.  Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res. 1997;88:82–87
  35. Ishihara S, Yabuta R, Tokura Y, et al.  Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease. Int J Hematol. 2000;72:223–228
  36. Jaffe ES, Chan JK, Su IJ, et al.  Report of the Workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103–111
  37. Katoh A, Ohshima K, Kanda M, et al.  Gastrointestinal T cell lymphoma: Predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells. Leuk Lymphoma. 2000;39:97–111
  38. Kawa-Ha K, Ishihara S, Ninomiya T, et al.  CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest. 1989;84:51–55
  39. Kern WF, Spier CM, Hanneman EH, et al.  Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement. Blood. 1992;79:2432–2437
  40. Kim GE, Cho JH, Yang WI, et al.  Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment. J Clin Oncol. 2000;18:54–63
  41. Kim WS, Song SY, Ahn YC, et al.  CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?. Ann Oncol. 2001;12:349–352
  42. Kim YJ, Park QE, Kim SH, et al.  Clinicopathologic findings of aggressive NK cell leukemia. Korean J Pathol. 2002;36(suppl, abstr):95
  43. Kwong YL, Chan AC, Liang R, et al.  CD56+ NK lymphomas: Clinicopathological features and prognosis. Br J Haematol. 1997;97:821–829
  44. Kwong YL, Wong KF, Chan LC, et al.  Large granular lymphocyte leukemia. A study of nine cases in a Chinese population. Am J Clin Pathol. 1995;103:76–81
  45. Lei KI, Chan LY, Chan WY, et al.  Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol. 2000;111:239–246
  46. Lei KI, Chan LY, Chan WY, et al.  Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma. Clin Cancer Res. 2002;8:29–34
  47. Lei KI, Suen JJ, Hui P, et al.  Primary nasal and nasopharyngeal lymphomas: A comparative study of clinical presentation and treatment outcome. Clin Oncol (R Coll Radiol). 1999;11:379–387
  48. Leroux D, Mugneret F, Callanan M, et al.  CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: A study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood. 2002;99:4154–4159
  49. Li YX, Coucke PA, Li JY, et al.  Primary non-Hodgkin’s lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer. 1998;83:449–456
  50. Liang R, Chen F, Lee CK, et al.  Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant. 1997;19:91–93
  51. Logsdon MD, Ha CS, Kavadi VS, et al.  Lymphoma of the nasal cavity and paranasal sinuses: Improved outcome and altered prognostic factors with combined modality therapy. Cancer. 1997;80:477–488
  52. Loughran TP. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1–14
  53. Lymphoma Study Group of Japanese Pathologists . The World Health Organization Classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Pathol Int. 2000;50:696–702
  54. Martin AR, Chan WC, Perry DA, et al.  Aggressive natural killer cell lymphoma of the small intestine. Mod Pathol. 1995;8:467–472
  55. Misago N, Ohshima K, Aiura S, et al.  Primary cutaneous T-cell lymphoma with an angiocentric growth pattern: Association with Epstein-Barr virus. Br J Dermatol. 1996;135:638–643
  56. Miyamoto T, Yoshino T, Takehisa T, et al.  Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: Clinicopathological findings of four cases. Br J Dermatol. 1998;139:481–487
  57. Mori KL, Egashira M, Oshimi K. Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis. Br J Haematol. 2001;115:225–228
  58. Mori N, Yamashita Y, Tsuzuki T, et al.  Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection. Histopathology. 2000;37:363–371
  59. Mori N, Yatabe Y, Oka K, et al.  Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation. Am J Pathol. 1996;149:699–705
  60. Mraz-Gernhard S, Natkunam Y, Hoppe RT, et al.  Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol. 2001;19:2179–2188
  61. Nagafuji K, Fujisaki T, Arima F, et al.  L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Int J Hematol. 2001;74:447–450
  62. Nakamura S, Katoh E, Koshikawa T, et al.  Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathol Int. 1997;47:38–53
  63. Nakamura S, Suchi T, Koshikawa T, et al.  Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol. 1995;19:284–296
  64. Ng CS, Chan JK, Cheng PN, et al.  Nasal T-cell lymphoma associated with hemophagocytic syndrome. Cancer. 1986;58:67–71
  65. Ng CS, Chan JK, Lo ST. Expression of natural killer cell markers in non-Hodgkin’s lymphomas. Hum Pathol. 1987;18:1257–1262
  66. Ng CS, Lo ST, Chan JK, et al.  CD56+ putative natural killer cell lymphomas: Production of cytolytic effectors and related proteins mediating tumor cell apoptosis?. Hum Pathol. 1997;28:1276–1282
  67. Obama K, Tara M, Niina K. L-asparaginase induced complete remission in Epstein-Barr virus positive, multidrug resistant, cutaneous T-cell lymphoma. Int J Hematol. 1999;69:260–262
  68. Ohno T, Yamaguchi M, Oka K, et al.  Frequent expression of CD3 epsilon in CD3 (Leu 4)-negative nasal T-cell lymphomas. Leukemia. 1995;9:44–52
  69. Okuda T, Sakamoto S, Deguchi T, et al.  Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. Am J Hematol. 1991;38:321–323
  70. Ooi GC, Chim CS, Liang R, et al.  Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity. AJR Am J Roentgenol. 2000;174:1141–1145
  71. Oshimi K. Lymphoproliferative disorders of natural killer cells. Int J Hematol. 1996;63:279–290
  72. Oshimi K, Yamada O, Kaneko T, et al.  Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia. 1993;7:782–788
  73. Petrella T, Delfau-Larue MH, Caillot D, et al.  Nasopharyngeal lymphomas: further evidence for a natural killer cell origin. Hum Pathol. 1996;27:827–833
  74. Rabbani GR, Phyliky RL, Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol. 1999;106:960–966
  75. Ribrag V, Ell Hajj M, Janot F, et al.  Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia. 2001;15:1123–1126
  76. Rodriguez J, Romaguera JE, Manning J, et al.  Nasal-type T/NK lymphomas: A clinicopathologic study of 13 cases. Leuk Lymphoma. 2000;39:139–144
  77. Rudiger T, Weisenburger DD, Anderson JR, et al.  Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): Results from the Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 2002;13:140–149
  78. Sakata K, Hareyama M, Ohuchi A, et al.  Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol. 1997;36:307–311
  79. Sato K, Kimura F, Nakamura Y, et al.  An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand. Br J Haematol. 1996;94:379–382
  80. Shikama N, Izuno I, Oguchi M, et al.  Clinical stage IE primary lymphoma of the nasal cavity: Radiation therapy and chemotherapy. Radiology. 1997;204:467–470
  81. Shimodaira S, Ishida F, Kobayashi H, et al.  The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage. Br J Haematol. 1995;90:578–584
  82. Siu LL, Chan JK, Kwong YL. Natural killer cell malignancies: Clinicopathologic and molecular features. Histol Histopathol. 2002;17:539–554
  83. Siu LL, Chan JKC, Wong KF, et al.  Specific patterns of gene methylation in natural killer cell lymphoma: p73 is consistently involved. Am J Pathol. 2002;160:59–66
  84. Suzumiya J, Takeshita M, Kimura N, et al.  Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood. 1994;83:2255–2260
  85. Takahashi N, Miura I, Chubachi A, et al.  A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol. 2001;74:303–308
  86. Takeshita M, Kimura N, Suzumiya J, et al.  Angiocentric lymphoma with granulomatous panniculitis in the skin expressing natural killer cell and large granular T-cell phenotypes. Virchows Arch. 1994;425:499–504
  87. Takeshita M, Yamamoto M, Kikuchi M, et al.  Angiodestruction and tissue necrosis of skin-involving CD56+ NK/T-cell lymphoma are influenced by expression of cell adhesion molecules and cytotoxic granule and apoptosis-related proteins. Am J Clin Pathol. 2000;113:201–211
  88. Tanaka M, Suda T, Haze K, et al.  Fas ligand in human serum. Nat Med. 1996;2:317–322
  89. Tefferi A. Chronic natural killer cell lymphocytosis. Leuk Lymphoma. 1996;20:245–248
  90. Tefferi A, Li CY, Witzig TE, et al.  Chronic natural killer cell lymphocytosis: A descriptive clinical study. Blood. 1994;84:2721–2725
  91. Tien HF, Su IJ, Tang JL, et al.  Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas. Br J Haematol. 1997;97:621–625
  92. Wong KF. Genetic changes in natural killer cell neoplasms. Leuk Res. 2002;26:977–978
  93. Wong KF, Chan JK, Ng CS. CD56 (NCAM)-positive malignant lymphoma. Leuk Lymphoma. 1994;14:29–36
  94. Wong KF, Chan JK, Ng CS, et al.  CD56 (NKH1)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol. 1992;23:798–804
  95. Wong KF, Zhang YM, Chan JK. Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia—Is there a consistent pattern?. Leuk Lymphoma. 1999;34:241–250
  96. Yamaguchi M, Kita K, Miwa H, et al.  Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer. 1995;76:2351–2356
  97. Yamaguchi M, Shoko O, Yoshihito N. Treatment outcome of nasal NK-cell lymphoma: A report of 12 consecutively diagnosed cases and a review of the literature. J Clin Exp Hematopathol. 2001;41:93–99
  98. Yong W, Zhang Y, Zheng W. The efficacy of L-asparaginase in the treatment of refractory midline peripheral T-cell lymphoma. Zhonghua Xue Ye Xue Za Zhi. 2000;21:577–579
  99. Yong W, Zheng W, Zhang Y, et al.  Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma. Zhonghua Yi Xue Za Zhi. 2001;81:773–775

PII: S0037-1963(03)00136-7

Seminars in Hematology
Volume 40, Issue 3 , Pages 221-232 , July 2003

Article Tools

* Image Usage & Resolution